Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease

Keyphrases

• Kindred 100%
• Medullary Thyroid Carcinoma 100%
• Hirschsprung Disease 100%
• RET Proto-oncogene 100%
• Multiple Endocrine Neoplasia Type 2 (MEN2) 80%
• Cysteine 80%
• Familial Medullary Thyroid Carcinoma 60%
• Germline mutation 40%
• RET Gene 40%
• Amino Acid Variation 20%
• Codon 20%
• Japanese Family 20%
• Biochemical Analysis 20%
• Amino Acid Substitution 20%
• RET mutation 20%
• Cysteine Residues 20%
• Biological Analysis 20%
• Hereditary Disease 20%
• RET Protein 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cysteine 100%
• Thyroid Medullary Carcinoma 100%
• Hirschsprung's Disease 100%
• Amino Acid 40%
• Multiple Endocrine Neoplasia 40%
• Disease 20%
• Serine 20%
• Genetic Disorder 20%
• Multiple Endocrine Neoplasia Type 2a 20%
• Multiple Endocrine Neoplasia Type 2b 20%

Biochemistry, Genetics and Molecular Biology

• Cysteine 100%
• RET Proto-Oncogene 100%
• Germline Mutation 40%
• Amino Acids 20%
• Codon 20%
• Serine 20%
• Biochemical Analysis 20%
• Amino Acid Substitution 20%